Abstract:Background Primary sclerosing cholangitis (PSC) is a progressive immune-mediated liver disease, for which no medical therapy has been shown to slow disease progression. However, the horizon for new therapies is encouraging, with several innovative clinical trials in progress. Despite these advancements, there is considerable heterogeneity in the outcomes studied, with lack of consensus as to what outcomes to measure, when to measure and how to measure. Furthermore, there has been a paradigm shift in PSC treatment targets over recent years, moving from biochemistry-based endpoints to histological assessment of liver fibrosis, imaging-based biomarkers and patient-reported outcome measures. The abundance of new interventional trials and evolving endpoints pose opportunities for all stakeholders involved in evaluating novel therapies. To this effect, there is a need to harmonise measures used in clinical trials through the development of a core outcome set (COS). Methods and analysis Synthesis of a PSC-specific COS will be conducted in four stages. Initially, a systematic literature review will be performed to identify outcomes previously used in PSC trials, followed by semistructured qualitative interviews conducted with key stakeholders. The latter may include patients, clinicians, researchers, pharmaceutical industry representatives and healthcare payers and regulatory agencies, to identify additional outcomes of importance. Using the outcomes generated from the literature review and stakeholder interviews, an international two-round Delphi survey will be conducted to prioritise outcomes for inclusion in the COS. Finally, a consensus meeting will be convened to ratify the COS and disseminate findings for application in future PSC trials. Ethics and dissemination Ethical approval has been granted by the East Midlands—Leicester Central Research Ethics Committee (Ref: 24/EM/0126) for this study. The COS from this study will be widely disseminated including publication in peer-reviewed journals, international conferences, promotion through patient-support groups and made available on the Core Outcomes Measurement in Effectiveness Trials (COMET) database. Trial registration number 1239.

Comparative Study between Intact PTH and Fragments of PTH in Patients on Hemodialysis and CAPD

Research progress of core outcome sets in the emergency and critical care patients/

Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes

Developing a core outcome set for evaluating medication adherence interventions for adults prescribed long-term medication in primary care

A new PR-D (Proportional Resonant and Derivative) controller for resonance damping in a grid connected reverse voltage topology multi-level inverter

Rosacea Core Domain Set for Clinical Trials and Practice

Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care

Core outcome set for clinical trials of stent implantation in coronary heart disease -- a systematic review and mixed-method consensus study

Core outcome set for pulmonary rehabilitation of patients with COPD: results of a modified Delphi survey

Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)

Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis

Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis

PRACTICE: Development of a Core Outcome Set for Trials of Physical Rehabilitation in Critical Illness

Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol

Patient perspectives on recall period and response options in patient-reported outcome measures for chronic rhinosinusitis symptomatology: An international multi-centered study

Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol

Treatment of Chronic Pulmonary Heart Disease with Traditional Chinese Medicine: A Protocol for the Development of a Core Outcome Set (COS-TCM-CPHD)

Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

Core outcome sets for use in effectiveness trials involving people with bipolar and schizophrenia in a community-based setting (PARTNERS2): study protocol for the development of two core outcome sets

Changes in Insecticide Resistance of the Rice Striped Stem Borer (Lepidoptera: Crambidae)

Core outcome sets for myocardial infarction in clinical trials of traditional Chinese medicine and Western medicine